Navigation Links
Mergent, Inc. Announces Changes to the HealthShares(TM) Infectious Disease and HealthShares(TM) Composite Indexes
Date:8/8/2008

NEW YORK, Aug. 8 /PRNewswire/ -- Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares Exchange Traded Funds, today announced the following changes effective on the opening of trading on Monday August 11, 2008: Enzo Biochem Inc. will replace Toyoma Chemical Co. (Tokyo, Japan: 4518) in the HealthShares(TM) Infectious Disease Index and the HealthShares(TM) Composite Index.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080204/CLM073LOGO)

Companies included in the HealthShares(TM) Infectious Disease Index are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of infectious diseases related to antibacterial, antifungal and antiviral indications, by means of small molecules, protein therapy and vaccines. The HealthShares(TM) Composite Index consists of the 80 largest companies by market capitalization, selecting the top 5 companies in market capitalization from each of the Composite Eligible Indexes.

About Mergent

Mergent, Inc. is a leading provider of business and financial data on global publicly listed companies. Based in the U.S., the company maintains a strong global presence, with offices in New York, Charlotte, San Diego, London, Tokyo and Melbourne.

Founded in 1900, Mergent operates the longest continuously collected database of: descriptive and fundamental information on domestic and international companies; pricing and terms and conditions data on fixed income and equity securities; and corporate action data. In addition, Mergent develops and licenses equity and fixed income investment products based on its proprietary investment methodologies. Mergent-licensed products have approximately $3.5 billion in assets under management and are offered by major investment management firms. Mergent's index cal
'/>"/>

SOURCE Mergent, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Mergent, Inc. Announces Changes to the HealthShares(TM) Ophthalmology Index
2. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, Dermatology and Wound Care Index and Orthopedic Repair Index - Correction
3. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, HealthShares(TM) Dermatology and Wound Care Index and HealthShares(TM) Orthopedic Repair Index
4. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes
5. TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results
6. Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries
7. Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
8. SXC Health Solutions announces second quarter financial results
9. Medifast Announces Second Quarter 2008 Financial Results
10. Bariatric Advantage Announces New Higher-Potency Iron Supplement for Weight Loss Surgery Patients
11. Nektar Therapeutics Announces Second Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...swire-USNewswire/ -- The United States Conference ...tial changes its health reform bill in order to ke...nscience protection on abortion, protect access to...visions for adequate affordability. ,, The bish...s disappointment" that creates new and unacceptabl...
(Date:11/20/2009)...wswire-FirstCall/ -- Rates of infection by the 200...ober, but the pandemic flu virus continues to be a...cluding the elderly, according to a new report by ... world,s leading provider of diagnostic testing, i... Quest Diagnostics Health Trends(TM) Report "Testi...
(Date:11/20/2009)...20 Cardio Vascular,Medic....COM , a leading,developer of advanced cardiovascu...ompany,s Board of Directors has decided to initiat...r East for its proprietary next-generation,"steera...A) procedures. , Cardio Vascular Medical ...
(Date:11/20/2009)...ire-FirstCall/ -- SIRIUS XM Radio (Nasdaq: SIRI... Radio Reports: What Every Women Needs to Know Ab...eran journalist Perri Peltz. ,, (Logo: http:/... ) ,, Doctor Radio Reports: What Every Woman...er 21 live at 10:00 am ET on Doctor Radio , SIRIU...
(Date:11/20/2009)... with chronic kidney disease often fail to detect ...increasing a child,s risk for serious heart proble...ren,s Center and other institutions. A report of t...can Society of Nephrology. , Researchers compa...gular doctor visits to readings obtained via a spe...
Breaking Medicine News(10 mins):Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:High blood pressure easy to miss in children with kidney disease 2
...mber 11, 2007 Takeda Pharmaceuticals North Americ...one HCl) data conducted by A. Michael Lincoff, M.D...ed in the Journal of the American Medical Associat...tients with diabetes versus control therapy. , ...
...ostate biopsies resulted in a cancer diagnosis amo...e first biopsy did not find cancer often had multi...ance of a cancer diagnosis. , While PSA (prostat...Nonetheless, it remains unclear whether or not PSA...
...n now have another good reason to consider taking ...s an enlarged prostate and reduces the risk of get...om the Southwest Oncology Group strongly suggests ...ncers early, when they are most easily treatable. ...
...arker, not a cause, of renal trouble, study sugges...-- Lowering blood levels of an inflammation-linke...th serious kidney disease live any longer, new res...e who took extra folic acid, vitamin B6 and vitami...
...11 Dr. Walter,Cottrell, Pennsylvania Game Commiss...e test result from an adult female deer has confir...een found in Beaver County., "This outbreak of EH...dition, the fact that we are finding EHD earlier,t...
...s Conclude Sweetener Is Safe Across Population ...Sept. 11 A report published in the,September issu...sue 8, pp.,629-727) systematically evaluates virtu...of eight recognized scientists,from research insti...
Other Medicine News:Health News:Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association 2Health News:Other highlights in the September 11 JNCI 2Health News:Other highlights in the September 11 JNCI 3Health News:Generic prostate drug helps find high-risk cancers early 2Health News:Generic prostate drug helps find high-risk cancers early 3Health News:Lowering Blood Protein Won't Help Kidney Patients 2Health News:Lowering Blood Protein Won't Help Kidney Patients 3Health News:PA Game Commission: EHD Outbreak Update: Test Results Confirm EHD In Beaver County 2Health News:PA Game Commission: EHD Outbreak Update: Test Results Confirm EHD In Beaver County 3Health News:PA Game Commission: EHD Outbreak Update: Test Results Confirm EHD In Beaver County 4Health News:New Expert Report Dispels Common Myths About Aspartame 2Health News:New Expert Report Dispels Common Myths About Aspartame 3
(Date:11/20/2009)..., , NATICK, Mass. and LONDON, Nov. 20 /P...ion (NYSE: BSX ) today announced that it has rec... Administration (FDA) and CE Mark approval to mark...nt for the treatment of malignant esophageal stric...with resectable or non-resectable esophageal cance...
(Date:11/20/2009)..., , HOUSTON, Nov. 20 /PRNewswire-FirstC...nounced that Dan Moore, President and Chief Execut...cer, will present at the 21st Annual Piper Jaffray...December 2, 2009 at 12:00 PM EST. The conference ...al slides will be presented. Piper Jaffray will h...
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewsw...y) (NYSE: BDX ) today announced the completion o... Michigan-based company that develops and manufact...atforms. ,, In May 2009, BD and HandyLab announ...ommercialize molecular assays on the HandyLab Jagu...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Drug Might Restore Sense of Smell 51357 1Drug Might Restore Sense of Smell 51357 2Drug Might Restore Sense of Smell 51357 3Texas Humane Legislation Network Calls for Puppy Mill Crackdown 51352 1Texas Humane Legislation Network Calls for Puppy Mill Crackdown 51352 2New Poll Shows Americans Continuing to Move Toward Pro Life Position on Abortion 51348 1New Poll Shows Americans Continuing to Move Toward Pro Life Position on Abortion 51348 2
...7 The Department of,Justice announced today that ...e on Cancer (CRC) to develop and publicize model c...new cancer treatments. The Department said,the lan...be used to help,increase efficiency in contract ne...ing the time needed to begin clinical trials., Th...
...pt. 17 Sanofi pasteur, the,vaccines division of t...s,sponsoring a Phase II clinical study exploring a... advanced-stage melanoma -- an often fatal form of...ons. Patients are being,enrolled in the United Sta...stigate the safety and efficacy of a therapeutic c...
Other Medicine Technology:Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 3Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 4Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 5
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: